Diligence memo · auto-generated · as of July 2, 2026

South Broward Endoscopy, L.L.C.

South Broward Endoscopy, L.L.C. looks under-valued against its niche peers and is active on financing cadence.

SourceModeled below same-niche peers while still financing on rhythm — a potential mispricing worth a closer look.

Businessfiled

South Broward Endoscopy, L.L.C. operates in Other Health Care, based in COOPER CITY.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

South Broward Endoscopy, L.L.C. has raised $1.8M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $1.0M on 2025-08-07.

Most recent recorded round closed around 2025-08-07.

Valuation (modeled)modeled

Provath models South Broward Endoscopy, L.L.C. at approximately $2.8M (range $854K–$5.5M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.66× the median modeled value of Seed Other Health Care companies in 2025–2027 (105 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 5 months.

Last raise 11 mo ago; this sector typically re-raises about every 14 months.

Raising on or ahead of the sector's normal rhythm.

The last round stepped up 1.3× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 45% of Other Health Care peers (5377 compared).

Modeled value ranks above 11% of those peers.

Closest niche peers: Xymogen, Inc., Willow Life Sciences, Inc., ManyClicks, Inc., Sterile State, Inc., Limber Prosthetics, Inc..

Peoplefiled

9 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.